SDC1 and plasma cell myeloma: Finally, to determine potential off‐target effects of ACSL inhibition in bone marrow (BM) microenvironment cells, we analyzed myeloma patient survival in relation to expression of ACSL expression in the CD138‐ BM cells from the CoMMpass dataset using single cell RNA‐sequencing data.